Hirotada Nagai
Direttore/Membro del Consiglio presso PorMedTec Co., Ltd.
Provenienza dei contatti di primo grado di Hirotada Nagai
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
PorMedTec Co., Ltd.
 PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments.
4
| Holding Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Hirotada Nagai tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Tokyo | College/University | Undergraduate Degree Graduate Degree | |
Japan Asia Investment Co. Ltd. (Private Equity)
 Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance Japan Asia Investment Co. Ltd (JAIC) is a private equity subsidary of Japan Asia Investment Co Ltd. founded in 1981. The firm is headquartered in Tokyo, Japan. | Investment Managers | Corporate Officer/Principal | |
JAIC America, Inc.
 JAIC America, Inc. Investment ManagersFinance JAIC America, Inc. (JAIC America) is a venture capital subsidiary of Japan Asia Investment Co., Ltd. founded in 1999. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
A-CUBE, Inc.
 A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Director/Board Member | |
Megakaryon Corp.
 Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Medical/Nursing Services | Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin | |
| M3i, Inc. | Investment Managers | Chief Executive Officer | |
| POC Clinical Research, Inc. | Director/Board Member | ||
| STEMRIM | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Giappone | 7 |
| Stati Uniti | 4 |
Settori
| Finance | 4 |
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 7 |
| Chief Executive Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 2 |
| Private Equity Investor | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Kazuhiro Umeda | 8 |
| Genjiro Miwa | 4 |
| Hiroshi Nagashima | 1 |
| Shinichiro Komoto | 1 |
- Borsa valori
- Insiders
- Hirotada Nagai
- Connessioni Società
